Alexander Fischer

Greater Columbus Convention & Visitors Bureau operates hotels. The company is headquartered in Columbus, OH.

The Columbus Partnership acts as a non-profit, membership-based CEO organization. It engages in all major projects that need strong civic leadership and intend to enhance the quality of our schools, arts and cultural organizations, or the development of downtown Columbus. The company was founded in 2002 and is headquartered in Columbus, OH.

Nationwide Children's Hospital engages in the provision of pediatric health care services. It specializes in otolaryngology services; gastroenterology, hepatology and nutrition; hematology, oncology, and blood and marrow transplant; neurology, and sports medicine. The company was founded in 1892 and is headquartered in Columbus, OH.

Columbus Downtown Development Corp. operates as a non-profit development corporation. its projects include Columbus Commons, Lazarus Building, Scioto Mile, and The Peninsula. The company was founded in 2002 and is headquartered in Columbus, OH.

N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.

One Columbus is a business collective focused on promoting economic growth in the Central Ohio region. The private company is based in Columbus, OH. The company's mission is to attract and retain businesses in the area, positioning it as a strategic business hub.

Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone.